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Abstract
Aim: Human chorionic gonadotropin (hCG) is produced
by fetal trophoblast cells and secreted into maternal cir-
culation mainly in the first trimester of pregnancy. Anoth-
er glycoprotein, glycodelin A, is one of the main products
of the maternal decidua during this period. The purpose
of this study was to investigate the effect of glycodelin A
on hCG release by isolated cytotrophoblast cells in vitro.
Methods: Cytotrophoblast cells were prepared from
human first trimester placenta and incubated with varying
concentrations of glycodelin A. Supernatants were
assayed for hCG protein concentrations, and quantifi-
cation of beta hCG mRNA was carried out by RT-PCR.
Expression of hCG was analysed in stimulated tro-
phoblast cells and in unstimulated controls by
immunocytochemistry.
Results: Glycodelin A induces a dose-dependent
increase of hCG production. An increase of hCG expres-
sion was measured at 100 and 200 mg/mL glycodelin-A
treatment in trophoblast cell culture by TaqMan assay on
mRNA level. We found a moderate staining of hCG in
control trophoblast cells, whereas a strong hCG staining
was seen in glycodelin A-treated trophoblast cells.
Conclusions: HCG is a marker for the differentiation pro-
cess of trophoblast cells. Our results suggest that gly-
codelin A secreted by the decidualized endometrium is
involved in the regulation of hormones produced by the
trophoblast.
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Introduction
Glycodelin, previously known as placental protein 14
(PP14), is expressed in glandular epithelium of the endo-
metrium w20x and decidua w19x. Glycodelin suppresses
the cytolytic capacity of NK-cells (Natural Killer Cells) in
vitro w32x and it stimulates the Th2-type cytokine pro-
duction in monocytes w28x, shown by an increased pro-
duction of IL-6 and IL-10 following glycodelin exposure
w25, 26x. Glycodelin directly inhibits T cell activity w39x in
an early phase of activation by diminishing T cell
responses in the contact site at the time of T cell receptor
triggering and inducing T cell apoptosis w38x. Our own
investigations w48x suggest a relationship between se-
rum levels of PP14 and threatened abortion, whereby
serum PP14 levels were significantly lower in patients
with threatened abortion at 10 to 20 weeks of gestation
than in normal pregnancies. Glycodelin was shown to
have a molecular weight of 28 kDa with two identical
subunits held together by non-covalent bonds and a car-
bohydrate content of 17.5% with a unique carbohydrate
configuration. Glycodelin, isolated from amniotic fluid
(glycodelin A, GdA), contains fucosylated LacdiNAc
structures that are very unusual for mammals w8x. Jul-
kunen and co-workers confirmed the homology between
GdA and b-lactoglobulins by deducing its complete ami-
no acid sequence w22x. A similar glycoprotein, glycodelin
S, is found in seminal plasma, but it is differentially gly-
cosylated from GdA w23x.
It is assumed that GdA plays an important role during
implantation and the early survival of the developing feto-
placental unit. GdA serum levels increase on the 14th day
after conception but do not differ from levels in the late
secretory phase w21x. A more significant rise of glycodelin
A has been found on the 21st and 28th day of pregnancy.
The highest serum glycodelin A concentrations have
been detected between six and 12 weeks of gestation,
followed by a decrease and plateau at 24 weeks. Jul-
kunen et al. w21x measured the content of GdA in amni-
otic fluid and found the highest values between the 12th
and 20th week of gestation with a highest level of
232 mg/mL. This is nearly one thousand fold higher than
the serum glycodelin A for equivalent gestational age.
Even early radioimmunoassays established that the GdA
secretory pattern resembles that of human chorionic
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gonadotropin (hCG) w42x. Because these two proteins are
different with regards to their tissue of origin (GdA is pro-
duced by maternal decidua but hCG is produced by fetal
trophoblast), no functional relationship between hCG and
GdA is suggested. It is generally accepted that hCG is
produced by the syncytiotrophoblast w45x, but Hoshina
et al. w12x and Boime w3x speculated that hCG could also
be produced by cytotrophoblast cells, although the reg-
ulation of placental hCG-b expression is still not well
understood w27x. In a preliminary study we investigated
the expression of bhCG mRNA in panels of different
human normal tissues and isolated term trophoblast cells
w40x. We found a bhCG stimulation by glycodelin A on
mRNA level. The effect of glycodelin A on bhCG regu-
lation is time-dependent. We observed a short increase
of bhCG mRNA copy numbers 60 min after glycodelin A
treatment. In another study, normal preparations of
human term trophoblast cells in vitro were used to inves-
tigate the effect of glycodelin A on endocrine trophoblast
function by measuring the release of hCG in culture
medium w17x. Because production of both GdA and hCG
are highest in the first trimester of pregnancy, we under-
took the present study to investigate the influence and
relationship of glycodelin A on bhCG-mRNA and protein
expression in isolated first trimester trophoblast cells.
Materials and methods
Placental tissue was obtained from terminations of normal preg-
nancies between the seventh and 12th week of gestation. A total
of 14 placentas was obtained after curettage treatment. All
women were between 22 and 36 years, had a singleton preg-
nancy and showed no abnormalties until the moment of termi-
nation. The study was approved by the ethical committee of the
University of Rostock, and informed consent to use the tissue
was obtained from each patient.
Dulbecco’s modified Eagle’s medium (DMEM), Hank’s bal-
anced salt solution (HBSS) without Ca2q and Mg2q, antibiotic
and antimycotic solutions, Ultroser G and trypsin-EDTA were
obtained from GibcoBRL Life Technologies (Paisley, UK). Trypsin
type 3 and DNAse I were obtained from Sigma (Taufkirchen, Ger-
many) and HEPES buffer (1M) and inactivated fetal calf serum
(FCS) came from Biochrom (Berlin, Germany).
Preparation and culture of villous cytotrophoblast
cells
CTBs were prepared according to a published protocol w15x.
Briefly, first trimester placental tissue was minced and digested
three times with trypsin and DNAse I in HBSS-HEPES. First puri-
fication was performed on a percoll gradient. After centrifuga-
tion, CTBs were aspirated and the villous cytotrophoblast cells
were immunopurified using antibodies against CD45 and CD9
(Dianova, Hamburg, Germany) and a magnetic cell sorting col-
umn (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) to
eliminate contaminating leukocytes (CD45), extravillous tropho-
blast cells, fibroblasts and other mesenchymal components
(CD9). The identity of the isolated villous cytotrophoblast cells
was determined morphologically by light microscopy and by
immunostaining with a monoclonal mouse anti-cytokeratin 7
antibody (Progen Biotechnik, Heidelberg, Germany). In addition,
cells were checked for possible expression of the Thomsen-Frie-
denreich epitope, which is a marker for syncytiotrophoblast w15x.
Isolated cells contained less than 1% digested fragments of the
syncytiotrophoblast. Cells were cultured in DMEM medium with
10% inactivated FCS and with antibiotics and antimycotics.
Purification of glycodelin A from amniotic fluid
Glycodelin A was purified from amniotic fluid obtained from the
pooled samples obtained from women with normal singleton
pregnancies that for diagnostic purposes by two anion
exchange chromatography steps, gel filtration and two hydro-
phobic interaction chromatography steps as described else-
where w17x. Briefly, amniotic fluid was loaded onto a
DEAE-Sepharose column and fractionated on a 50–500 mM
NH4HCO3-gradient followed by gel filtration and a second anion
exchange chromatography step on Resource Q. Final purifica-
tion was obtained by hydrophobic interaction chromatography
on Octyl-Sepharose and Resource-Phe (all columns by Amers-
ham Pharmacia Biotech AB, Uppsala, Sweden).
Identification of glycodelin A by Western blot
analysis
Western blot analysis of purified glycodelin A was carried out
according to the procedure published elsewhere w2x. Briefly, gly-
codelin A was detected with a polyclonal rabbit anti glycodelin
A antibody (10 mg/mL, Bioscience, Berlin, Germany) followed by
anti-rabbit IgG conjugated to HRP (1:1000, Dianova, Hamburg,
Germany) and stained with 3-amino-9-ethyl carbazol (Sigma).
Treatment of trophoblast cultures with glycodelin A
Freshly isolated trophoblast cells were incubated at concentra-
tions of 1=106 cells/mL in 24-well plates (Greiner Labortechnik,
Solingen, Germany) in humidified 5% CO2-95% air at 378C in
the presence of 50 mg/mL, 100 mg/mL and 200 mg/mL glyco-
delin A. Untreated cell cultures of the same placentas were used
as controls. In addition, samples of the transferrin containing
fraction of amniotic fluid were also used as controls to verify the
effect of glycodelin A. The effect of glycodelin A on the secretion
of markers for syncytiotrophoblasts was studied by comparing
the kinetics of hCG mRNA or protein production of untreated
(controls) and glycodelin A-stimulated trophoblast cell cultures
simultaneously. All experiments were carried out at least in
triplicates.
Identification of hCGb-mRNA transcripts (real-time
RT-PCR)
Total RNA was prepared using the acid guanidium thiocyanate-
phenol-chloroform protocol w6x. Quality of the RNA samples was
determined by electrophoresis through denaturing agarose gels
and staining with ethidium bromide. The RNA was quantified and
evaluated for purity by UV spectrophotometry. To further assess
the quality of RNA, all specimens were tested by analysis of
housekeeping gene expression using conventional RT-PCR.
HCG-b primers and probe were designed using the Primer
Express 1.0 program (PE Applied Biosystems, Foster City, CA).
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Figure 1 SDS-PAGE analysis of glycodelin A (lane 1, stained
with Coomassie Brillant Blue G250, Amersham Biosciences),
lane 2; glycodelin A, Western blot analysis detected with a poly-
clonal glycodelin antibody (Bioscience), lane 3; protein marker
(New England Biolabs)
Oligonucleotide hybridisation probe and primers with the follow-
ing sequences were synthesized as follows: TaqMan probe 59-
CTG CTG AGC ATG GGC GGG ACA T (exon 2), forward primer
59-CCA AGG ATG GAG ATG TTC CAG, and reverse primer 59-
GCA CGC GGG TCA TGG T. The reverse primer was designed
to span an exon/intron junction to avoid amplification of DNA
sequences, whereas the forward primer was complementary to
the 39-end of exon 1. Primers and probe were obtained from
Applied Biosystems GmbH (Weiterstadt, Germany). The primers
yielded a RT-PCR product of 199 nucleotides w40x.
The preparation of RNA standard and quantification of bhCG
mRNA expression by ABI PRISM 7700 Sequence Detection Sys-
tem (PE Applied Biosystems) have been published in detail pre-
viously w40, 41x. The TaqMan EZ RT-PCR Kit (PE, Applied
Biosystems) was used for reverse transcription and amplification
of both targets and standards. All RT-PCR reactions were per-
formed in triplicate with a final volume of 25 mL. RT-PCR con-
ditions were optimised for primers (300 nM), probe (100 nM),
template (100 ng), and manganese acetate concentrations
(3 mM). The reaction conditions were 2 min at 508C, 30 min at
608C, 2 min at 958C, 40 cycles with 20 sec at 948C and 1 min
at 608C w41x.
Analysis of hCG protein production
At designated times (24 h and 48 h) aliquots of the culture media
were taken, frozen at y408C and replaced with fresh medium.
Cells were cultured for up to 48 h. Secretion of hCG was ana-
lysed by the automated hormone analyser ‘‘Immulite’’ (DPC Bier-
mann GmbH, Bad Nauheim, Germany). This assay detects,
besides normal hCG, the five irregular forms of bhCG including
hyperglycosylated hCG. The results of this assay agree with
those of the RIA, and it avoids false-positive values in the sam-
ples tested w7x. The sensitivity of the used assay is 1.1 mIU/mL,
and the detection limit is 5000 mIU/mL.
Immunocytochemistry
Isolated trophoblast cells were incubated with varying concen-
trations of glycodelin (0, 100 mg/mL and 200 mg/mL) and grown
on three-well multitest slides (Roth, Karlsruhe, Germany) for up
to 72 h. At designated times, medium was withdrawn, the slides
were air-dried, wrapped and stored aty808C. After thawing, the
cells were briefly fixed with formalin (Merck, Darmstadt, Ger-
many; 5% in PBS, 5 min) and permeabilized with digitonin (Ysat,
Wernigerode, Germany; 6 mg/mL in PBS, 15 min). The antibody
against hCG was diluted to 5 mg/mL with PBS and incubated
with the slides overnight at 48C. As isotype controls of the anti-
hCG antibody normal mouse serum as well as a monoclonal
antibody against Glycodelin A (A87-B/D2, IgG) were incubated
with different slides overnight at 48C. After washing, Cy3-
labelled goat anti-mouse IgG, diluted 1:200, were used as sec-
ond antibodies for staining of hCG. Slides were examined with
a Zeiss (Jena, Germany) Axiophot photomicroscope. Digital
images were obtained with a digital camera system (Axiocam;
Zeiss) and saved on computer.
Statistical analysis
The SPSS/PC software package, version 6.01 (SPSS GmbH,
Munich, Germany), was used for collection, processing, and sta-
tistical analysis of all data. Statistical analysis was performed
using the non parametrical Wilcoxon’s signed rank tests for
comparison of the means. P-0.05 was considered statistically
significant.
Results
Purification of glycodelin A from amniotic fluid
SDS-PAGE of the purified protein showed one band at
28 kD (Figure 1, Lane 1). In addition, the purified protein
was checked for impurities of hCG by the automated
hormone analyser ‘‘Immulite’’ (DPC Biermann GmbH,
Bad Nauheim, Germany) and did not contain any hCG
traces. Identity of purified glycodelin A was checked by
Western blot analysis (Figure 1, Lane 2).
Stimulation of hCGb-mRNA production by glycodelin
A
An increase of hCGb-mRNA expression was measured
at 100 mg/mL and 200 mg/mL glycodelin A-treatment in
trophoblast cell cultures by the TaqMan assay. No sig-
nificant change of bhCG mRNA expression was seen in
the untreated control (Figure 2). Time- and dose-depend-
ency studies showed that the highest number of copies
was measured at the higher dose (200 mg/mL) after as
little as 30 min, whereas with the lower dose (100 mg/
mL) 60 min were required. In both cases the increase was
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Figure 2 Time-dependent quantification of bhCG mRNA copy numbers (mean values"SD, ns3 for every group) per 200 ng total
mRNA in glycodelin A (100 mg/mL, 200 mg/mL) – treated or untreated trophoblast cell cultures. Quantification was performed using
the external bhCG RNA standard run in parallel.
Figure 3 Effect of glycodelin A on the hCG production of cytotrophoblast cells in vitro. Data (mean"SD) represent hCG concen-
tration in aliquots of the culture media at designated times (ns4 for every group). Ps0.036 (100 mg/mL glycodelin A) and Ps0.028
(200 mg/mL glycodelin A) indicates the significance levels between controls and stimulated cultures. There was no significant differ-
ence observed between the hCG production of controls and cells stimulated with 50 mg/mL glycodelin A (P)0.05).
statistically significant (Ps0.046 and 0.028, respectively).
After 90 min, mRNA levels were almost indistinguishable
from the controls.
Stimulation of hCG protein production by glycodelin
A
The concentrations of hCG released by trophoblast cells,
incubated for 24 or 48 h with different concentrations of
glycodelin A (0, 50, 100, 200 mg/mL) are shown in Figure
3. The data indicate that glycodelin A stimulates hCG
protein production in trophoblast cells in a time and
dose-dependent manner. When trophoblast cells were
incubated with glycodelin A (50 mg), no significant rise
(Ps0.624) of hCG production was observed. A signifi-
cant increase in hCG production was found for higher
concentrations of glycodelin A (100 mg/mL Ps0.036;
200 mg/mL Ps0.028) after prolonged incubation (48 h).
Addition of 100 mg/mL glycodelin A led to a rise of the
hCG level by the factor 2.2, whereas addition of 200
mg/mL led to a rise of the hCG levels by the factor 3.7.
The transferrin containing fractions of amniotic fluid had
no effect on the hCG production of trophoblast cells and
showed the same values of hCG production as controls.
Expression of hCG on CTB as detected by
immunofluorescence
Isolated trophoblast cells from the first trimester of preg-
nancy showed moderate expression of hCG after 72 h of
cultivation and subsequent staining with the anti-hCG
antibody MS-1039-P, respectively. Results are docu-
mented in Figure 4 A. Glycodelin A-treated trophoblast
cells (100 mg/mL, 200 mg/mL) showed a stronger
expression of hCG. The same set of antibodies was used
as for investigations of controls. Results are documented
in Figure 4 B,C. Slides incubated with normal mouse
serum or monoclonal anti-GdA antibody A87-B/D2
showed no staining of cytotrophoblast cells (data not
shown) .
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Figure 4 Expression of hCG on cytotrophoblast cells cultured
without (A) or with 100 mg/mL glycodelin A (B) and 200 mg/mL
glycodelin A (C) after 72 h of incubation. Slides were stained for
hCG (mab MS-1039-P). Second antibodies were Cy3- labelled,
respectively. 63 = lens.
Comment
The physiological role of hCG during pregnancy is not
completely understood. It is generally assumed that hCG
production by the trophoblast stimulates progesterone
secretion, thus contributing to the maintenance of the
corpus luteum of pregnancy. Expression of hCG is
detectable as early as at the eight cell stage of the devel-
oping embryo w4x. An array of paracrine modulators of
hCG synthesis has been identified w14, 18, 29, 33x, but
less is known about the regulatory elements of the hCGb
gene because highly differentiated cells are required for
their regulation w1x.
This study shows that glycodelin A stimulates hCG in
isolated trophoblast cells in vitro at mRNA level. In addi-
tion, glycodelin A caused an increase in hCG release by
cultivated cytotrophoblast cells into the medium. This
increase was dose-dependent. Addition of 50 mg/mL gly-
codelin A did not lead to a significant increase of hCG
secretion. Addition of higher concentrations (100 mg/mL
and 200 mg/mL) of glycodelin A induced a significant
increase in secretion of hCG compared to unstimulated
controls in trophoblast cells. The range of concentrations
of glycodelin used for the experiments is similar to the
physiological range of this glycoprotein as found in amni-
otic fluid during the first trimester of pregnancy w44x. The
glycodelin concentration rises during the first eight to
nine weeks of gestation, and is maintained until
14–15 weeks of gestation w21x. During this time of preg-
nancy, fetus-derived trophoblast cells invade deeply into
the maternal decidua, and the contact between fetal and
maternal cells is most intimate w9x. Glycodelin A is the
main product of the decidua in the first trimester of preg-
nancy w19, 43x, whereas also IGF-BP1 and prolactin are
synthesized and secreted in high levels by decidual cells
w5, 10, 11, 13, 24, 31, 34, 47, 46x. Our results suggest a
stimulating effect of glycodelin A on hCG secretion of
trophoblasts. To investigate a possible induction of hCG
synthesis in trophoblasts by glycodelin A, real time RT-
PCR was used. The results showed a dose dependent
stimulating effect of glycodelin A of trophoblasts on the
bhCG mRNA level. There was no significant rise of hCGb
mRNA in unstimulated controls. The addition of high
amounts of glycodelin A (200 mg/mL) led to an immediate
increase of bhCG mRNA copy numbers by the factor 3
after only 30 min of incubation compared to unstimulated
controls. Addition of 100 mg/mL glycodelin A led to an
immediate increase of bhCG mRNA copy numbers by
the factor 2 after 60 min of incubation. This immediate
stimulation effect was also observed in former studies,
where glycodelin A stimulated bhCG mRNA synthesis in
term trophoblast cells w40x as well as in Jeg 3 trophoblast
tumor cells w2x. A delayed stimulation of hCG protein pro-
duction by glycodelin A was measured in both cell types,
which could be explained by a feedback inhibition of the
bhCG mRNA synthesis by hCG itself. Feedback inhibi-
tion of gene expression is a widespread phenomenon in
which the expression of a gene is downregulated by its
protein product. Feedback in eukaryotic cells involves
time delays resulting from transcription, transcript splic-
ing and processing, and protein synthesis w30x.
Thus, our results show that glycodelin A induces both
bhCG mRNA synthesis and secretion of hCG in tropho-
blast cells, although the exact mechanism of action of
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Table 1 Antibodies used in the study.
Antigen Clone Species and isotype Concentration/dilution Source
CD 45 CBL 124 Mouse IgG 1:100 Dianova
CD 9 CBL 560 Mouse IgG 1:100 Dianova
CK 7 Ks 7.18 Mouse IgG 1:50 Progen Biotechnik
Glycodelin – Rabbit IgG 10 mg/mL Bioscience
Glycodelin A A87-B/D2 Mouse IgG 5 mg/mL Nemod
hCG MS-1039-P Mouse IgG 5 mg/mL Dianova
TF A78 G/A7 Mouse IgM 1:4 Serotec
glycodelin A on trophoblast cells is not known. It is
already known that glycodelin A regulates uterine
immune responsiveness. It has been shown that decidual
extracts containing glycodelin A suppress thymidine
uptake in normal and mitogen-stimulated human mixed
lymphocyte cultures w37x. In addition, glycodelin A
decreased the synthesis of IL1 and IL2 and the expres-
sion of the IL2-receptor by mitogen-stimulated cells w35,
36x. Here we showed that glycodelin A is involved in
stimulation of first trimester trophoblast derived glyco-
protein hormone hCG. In a recently published study we
could show that glycodelin A induced a reduced expres-
sion of hPL in first trimester trophoblast cells. Expression
of MUC1 was not affected by glycodelin A. Freshly iso-
lated trophoblast cells showed no Thomsen-Friedenreich
(TF) expression, a marker for the syncytiotrophoblast and
extravillous trophoblast cells w15x but became positive for
this antigen after 96 h of cultivation. Glycodelin A stim-
ulated trophoblast cells inhibit TF-expression after 96 h
of cultivation and glycodelin A plasmids induced a sig-
nificantly higher hCG production in transfected cells
compared to cells transfected with the empty plasmid
w16x. Results obtained in both studies suggest that gly-
codelin A is involved in differentiation of trophoblast cells.
This is due to the fact that treatment of glycodelin A and
its plasmid transfected trophoblast cells stimulated hCG
production in isolated first trimester trophoblast cells and
inhibited hPL and TF expression.
In conclusion, we have shown that glycodelin A induc-
es synthesis of bhCG mRNA and secretion of hCG in
trophoblast cells. These results indicate a function of gly-
codelin A in trophoblast hCG production. But more infor-
mation about the exact mechanism of hCG regulation by
glycodelin A is required.
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